I reviewed the first instance judgment in Clifford Change v SocGen here. Soc Gen have unsuccessfully appealed, see Clifford Chance LLP & Anor v Societe Generale SA (Rev1) [2025] EWCA Civ 14, with Phillips LJ not taking up much space to do so. Viz the question whether Clifford Change LLP was bound, he holds [46] … Read more
By David Bautz, PhD NASDAQ:XFOR READ THE FULL XFOR RESEARCH REPORT Business Update Licensing Agreement with Norgine Includes €28.5 Million Upfront Payment On January 13, 2025, X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) announced an exclusive licensing and supply agreement with Norgine, a European specialty pharmaceutical company that generates greater than €500 million in annual revenues, that covers Europe, … Read more
Reports of a possible Russia-Ukraine peace agreement continue to bubble and churn. The latest is an apparent Russian rejection of a peace plan floated by the Trump transition team. Uncertainty over the specifics of an agreement is likely to continue at least until the new administration takes office. But potential provisions are almost certainly being … Read more
Dexia v Patrimonio del Trentino [2024] EWHC 2717 (KB) echoes Banca Intesa v Venezia in some of its main issues. It features capacity of foreign corporations to enter into legal transaction, relevance of lex incorporationis, validity of choice of court clause, and the impact of Brexit, with the judge prima facie accepting resurrection of the … Read more
Lunch breaks during meetings have become an increasingly important setting for confidential discussions between EU leaders, write Mareike Kleine and Samuel Huntington. But while these discussions make it easier to reach agreements, they raise critical questions about the trade-off between transparency and confidentiality in EU and global governance. In October 2024, EU ministers met informally … Read more